| Literature DB >> 29928140 |
Ewa Markiewicz1, Olusola Clement Idowu1.
Abstract
Human skin is a stratified endocrine organ with primary roles in protection against detrimental biochemical and biophysical factors in the environment. Environmental stress causes gradual accumulation of the macromolecular damage and clinical manifestations consistent with chronic inflammatory conditions and premature aging of the skin. Structural proteins of cell nucleus, the nuclear lamins and lamina-associated proteins, play an important role in the regulation of a number of signal transduction pathways associated with stress. The nuclear lamina proteins have been implicated in a number of degenerative disorders with frequent clinical manifestations of the skin conditions related to premature aging. Analysis of the molecular signatures in response of the skin to a range of damaging factors not only points at the likely involvement of the nuclear lamina in transmission of the signals between the environment and cell nucleus but also defines skin's sensitivity to stress, and therefore the capacities to counteract external damage in aging.Entities:
Keywords: fibroblast; genotoxic; nuclear lamina; progeroid syndrome
Year: 2018 PMID: 29928140 PMCID: PMC6003287 DOI: 10.2147/CCID.S163792
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Figure 1Schematic representation of the molecular mechanisms underlying the DNA damage, oxidative stress, inflammation, ECM degradation and pigmentation in UV-induced skin aging.
Abbreviations: ECM, extracellular matrix; ROS, reactive oxygen species; UV, ultraviolet.
Figure 2Schematic diagram representing the distinct and overlapping effects of relative air humidity, air pollution and UV radiation on human skin.
Abbreviation: UV, ultraviolet.
Summary of the molecular interactions and skin phenotypes associated with the nuclear lamina proteins
| Molecular interactions | Roles | Related genes and proteins | References |
|---|---|---|---|
| DNA damage response | Control of the levels of basal DNA damage, expression levels and recruitment of DNA repair factors | 53BP1 | |
| ATM | |||
| RAD | |||
| A(XPA) | |||
| Oxidative stress and intracellular redox homeostasis | Control of the basal levels of ROS, expression and activity of ROS-detoxifying enzymes in response to oxidative stress | CAT | |
| SOD | |||
| GST | |||
| Adaptive response to oxidative stress through conserved cysteine residues and cellular sensitivity to oxidative stress | LMNA | ||
| Lamin A-dependent regulation of activity of redox transcription factors | NRF2 | ||
| Inflammation Mechanotransduction | Control of the inflammatory responses via transcription | NF-kB | |
| Reciprocal association between lamin A and collagen levels (ECM elasticity) | LMNA | ||
| Skin phenotype: wrinkles, cutaneous atrophy present in HGPS, atypical WS, MAD | LMNA | ||
| Epidermal thickness and differentiation | Absence of all nuclear lamins in keratinocytes leads to hyperkeratosis in the animal models | LMNA, LMNB1, LMNB2 | |
| Skin phenotype: hyperkeratosis present in FPLD2, MAD | LMNA | ||
| Skin hydration and desquamation | Absence of all nuclear lamins in keratinocytes leads to ichthyosis and dehydration in the animal models | LMNA, LMNB1, LMNB2 | |
| Abnormal accumulation of lamin A/C in the epidermis prevents the formation of the stratum corneum in the animal models | AKT-1 | ||
| Skin phenotype: dry skin present in CMT, FPLD2, atypical WS | LMNA | ||
| Pigmentation | Indirect: functional interactions between ROS scavenging enzymes and the intermediates of melanogenesis | DHICA, SOD, CAT | |
| DCT, p53 | |||
| TYR, dopaquinone, GSH | |||
| Skin phenotype: hyperpigmentation, mottled pigmentation present in HGPS, FPLD2, MAD, atypical WS | LMNA |
Abbreviations: AhR, aryl hydrocarbon receptor; AP-1, activator protein 1; APL, acquired partial lipodystrophy; ATM, ataxia-telangiectasia mutated; ATR, ATM-related; BOS, Buschke–Ollendorff syndrome; CAT, catalase; CHK1/2, checkpoint kinase 1/2; CMT, Charcot–Marie–Tooth disease; COL, collagen; DCT, dopachrome tautomerase; DHICA, 5,6-dihydroxyindole-2-carboxylic acid; ECM, extracellular matrix; FoxO, Forkhead box; FPLD, familial partial lipodystrophy of the Dunnigan type; GCL, glutamate cysteine ligase; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; GST, glutathione transferase; HGPS, Hutchinson–Gilford progeria syndrome; HO-1, heme oxygenase-1; LMNA, lamin A/C; LMNB1, lamin B1; LMNB2, lamin B2; MAD, mandibuloacral dysplasia; MC1R, melanocortin 1 receptor; MMP, matrix metalloproteinase; a-MSH, alpha-melanocyte-stimulating hormone; mtDNA, mitochondrial DNA; NER, nucleotide excision repair; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; NMF, natural moisturizing factor; NQO1, NAD(P)H quinine oxidoreductase-1; NO2, nitrogen dioxide; NRF2, nuclear factor erythroid 2-related factor 2; p53, tumor protein 53; 53BP1, p53-binding protein 1; PAH, polycyclic aromatic hydrocarbon; PM, particulate matter; PRDX, peroxiredoxin; ROS, reactive oxygen species; RPA, replication protein A, SOD, superoxide dismutase; SNP, single nucleotide polymorphism; TEWL, transepidermal water loss; TrxR, thioredoxin reductase; TYR, tyrosinase; UV, ultraviolet; VOC, volatile organic compound; WS, Werner syndrome; XPA, xeroderma pigmentosum group A; XPE/DDB2, xeroderma pigmentosum complementation group E protein.